USD 37.85
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Revenue | 384.82 Billion | 344.6 Billion | 288.2 Billion | 267.74 Billion | 264.8 Billion | 259.4 Billion |
Cost of Revenue | 261.65 Billion | 224.91 Billion | 183.92 Billion | 173.07 Billion | 172.09 Billion | 176.66 Billion |
Gross Profit | 123.17 Billion | 119.69 Billion | 104.27 Billion | 94.67 Billion | 92.71 Billion | 82.74 Billion |
Operating Expenses | 89.78 Billion | 90.63 Billion | 68.54 Billion | 63.14 Billion | 65.23 Billion | 58.41 Billion |
Selling, General and Administrative Expenses | 73.7 Billion | 81.1 Billion | 71.33 Billion | 65.2 Billion | 66.06 Billion | 2.84 Billion |
Research and Development Expenses | 7.41 Billion | 6.34 Billion | 5.38 Billion | 5.31 Billion | 5.69 Billion | 5.49 Billion |
Other Expenses | 8.66 Billion | - | - | - | - | -697 Million |
Cost and Expenses | 342.77 Billion | 315.54 Billion | 252.47 Billion | 236.22 Billion | 237.32 Billion | 235.08 Billion |
Operating Income | 42.05 Billion | 29.05 Billion | 35.73 Billion | 31.52 Billion | 27.47 Billion | 24.32 Billion |
Interest Expense | 1.12 Billion | 1.07 Billion | 6.17 Billion | 1.92 Billion | 1.41 Billion | 317 Million |
Income Tax Expense | 12.09 Billion | 9.47 Billion | 10.45 Billion | 9.32 Billion | 8.37 Billion | 10.2 Billion |
Earnings before Tax | 41.68 Billion | 30.15 Billion | 30.07 Billion | 29.15 Billion | 26.69 Billion | 27.53 Billion |
Net Income | 29.18 Billion | 20.13 Billion | 18.47 Billion | 19.08 Billion | 18.28 Billion | 17.32 Billion |
Earnings Per Share Basic | 259.70 | 179.14 | 164.38 | 169.93 | 162.85 | 154.29 |
Earnings Per Share Diluted | 259.70 | 179.14 | 164.38 | 169.93 | 162.85 | 154.29 |
Weighted Average Shares Outstanding | 112.39 Million | 112.39 Million | 112.36 Million | 112.32 Million | 112.29 Million | 112.27 Million |
Weighted Average Shares Outstanding (Diluted) | 112.39 Million | 112.39 Million | 112.36 Million | 112.32 Million | 112.29 Million | 112.27 Million |
Gross Margin | 0.32 | 0.35 | 0.36 | 0.35 | 0.35 | 0.32 |
EBIT Margin | 0.19 | 0.20 | 0.21 | 0.19 | 0.18 | 0.16 |
Profit Margin | 0.08 | 0.06 | 0.06 | 0.07 | 0.07 | 0.07 |
EBITDA | 73.98 Billion | 74.34 Billion | 56.18 Billion | 52.5 Billion | 43.54 Billion | 38.66 Billion |
Earnings Before Tax Margin | 0.11 | 0.08 | 0.12 | 0.12 | 0.10 | 0.09 |
Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
---|---|---|---|---|---|---|
Revenue | 98.15 Billion | 384.82 Billion | 98.31 Billion | 97.81 Billion | 90.54 Billion | 344.6 Billion |
Cost of Revenue | 63.09 Billion | 261.65 Billion | 63.81 Billion | 64.82 Billion | 61.25 Billion | 224.91 Billion |
Gross Profit | 35.05 Billion | 123.17 Billion | 34.5 Billion | 32.99 Billion | 29.29 Billion | 119.69 Billion |
Operating Expenses | 23.45 Billion | 81.11 Billion | 22.11 Billion | 22.39 Billion | 21.15 Billion | 90.63 Billion |
Selling, General and Administrative Expenses | 21.46 Billion | - | 20.26 Billion | 20.52 Billion | 21.83 Billion | - |
Research and Development Expenses | 1.98 Billion | - | 1.84 Billion | 1.86 Billion | 1.71 Billion | - |
Other Expenses | - | - | - | - | - | - |
Cost and Expenses | 86.54 Billion | 342.76 Billion | 85.92 Billion | 87.21 Billion | 82.41 Billion | 315.54 Billion |
Operating Income | 11.6 Billion | 42.05 Billion | 12.39 Billion | 10.6 Billion | 8.13 Billion | 29.05 Billion |
Interest Expense | 394 Million | 1.12 Billion | 207 Million | 263 Million | 261 Million | 1.07 Billion |
Income Tax Expense | 3.79 Billion | 12.09 Billion | 2.87 Billion | 3.07 Billion | 2.35 Billion | 9.47 Billion |
Earnings before Tax | 11.18 Billion | 41.54 Billion | 12.24 Billion | 10.01 Billion | 8.12 Billion | 30.15 Billion |
Net Income | 7.28 Billion | 29.18 Billion | 9.31 Billion | 6.89 Billion | 5.69 Billion | 20.13 Billion |
Earnings Per Share Basic | 64.81 | - | 82.84 | 61.37 | 50.67 | - |
Earnings Per Share Diluted | 64.81 | - | 82.84 | 61.37 | 50.67 | - |
Weighted Average Shares Outstanding | 112.37 Million | 112.39 Million | 112.38 Million | 112.42 Million | 112.4 Million | 112.39 Million |
Weighted Average Shares Outstanding (Diluted) | 112.37 Million | 112.39 Million | 112.38 Million | 112.42 Million | 112.4 Million | 112.39 Million |
Gross Margin | 0.36 | 0.32 | 0.35 | 0.34 | 0.32 | 0.35 |
EBIT Margin | 0.21 | - | 0.21 | 0.19 | 0.18 | - |
Profit Margin | 0.07 | 0.08 | 0.09 | 0.07 | 0.06 | 0.06 |
EBITDA | 20.15 Billion | - | 20.51 Billion | 18.71 Billion | 16.23 Billion | - |
Earnings Before Tax Margin | 0.12 | 0.11 | 0.13 | 0.11 | 0.09 | 0.08 |
AJANTPHARM
7472
NSIT
GMLA
8028
NHIQ